Stamey James D, Natanegara Fanni, Seaman John W
Department of Statistical Science, Baylor University, Waco, TX 76798, USA.
J Biopharm Stat. 2013;23(4):790-803. doi: 10.1080/10543406.2013.789885.
In clinical trials, multiple outcomes are often collected in order to simultaneously assess effectiveness and safety. We develop a Bayesian procedure for determining the required sample size in a regression model where a continuous efficacy variable and a binary safety variable are observed. The sample size determination procedure is simulation based. The model accounts for correlation between the two variables. Through examples we demonstrate that savings in total sample size are possible when the correlation between these two variables is sufficiently high.
在临床试验中,通常会收集多个结果,以便同时评估有效性和安全性。我们开发了一种贝叶斯方法,用于确定回归模型中所需的样本量,在该模型中会观察到一个连续的疗效变量和一个二元安全性变量。样本量确定过程基于模拟。该模型考虑了两个变量之间的相关性。通过实例我们证明,当这两个变量之间的相关性足够高时,有可能节省总样本量。